Promising Neuroimaging Biomarkers in Depression

Area of Science:

• Neuroscience
• Psychiatry
• Medical Imaging

Background:

• Major depressive disorder (MDD) pathophysiology is increasingly studied using neuroimaging.
• Identifying reliable biomarkers is crucial for diagnosis and treatment prediction.

Purpose of the Study:

• To review various neuroimaging methodologies for identifying biomarkers in MDD.
• To summarize promising fronto-limbic regions as potential biomarkers for MDD.

Main Methods:

• Literature review of neuroimaging studies including MRI, magnetoencephalography, near-infrared spectroscopy, electroencephalography, PET, and SPECT.
• Analysis of findings related to specific brain regions like the frontal lobes and limbic system.

Main Results:

• Magnetic resonance imaging and magnetoencephalography suggest the anterior cingulate cortex, dorsolateral prefrontal cortex, and orbitofrontal cortex as potential biomarkers.
• Limbic regions including the hippocampus and amygdala are also identified as promising biomarkers.
• Near-infrared spectroscopy, electroencephalography, PET, and SPECT studies corroborate the role of frontal and limbic regions, with PET/SPECT also highlighting brainstem and midbrain involvement.

Conclusions:

• Frontal and limbic regions show significant promise as neuroimaging biomarkers for MDD.
• These biomarkers may be valuable for predicting antidepressant treatment response and understanding MDD's underlying pathophysiology.
• Cognitive control and emotion regulation functions within these regions are key to biomarker development.